168 related articles for article (PubMed ID: 9556996)
1. [Myocardial tissue vitality: clinical relevance, pathophysiology and identification].
Bax JJ; Cornel JH; Poldermans D; van Eck-Smit BL; van der Wall EE
Ned Tijdschr Geneeskd; 1998 Jan; 142(2):67-71. PubMed ID: 9556996
[TBL] [Abstract][Full Text] [Related]
2. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2005; 5(16):1-167. PubMed ID: 23074467
[TBL] [Abstract][Full Text] [Related]
3. Prediction of improvement of regional left ventricular function after revascularization using different perfusion-metabolism criteria.
Bax JJ; Visser FC; Elhendy A; Poldermans D; Cornel JH; van Lingen A; Boersma E; Sloof GW; Fioretti PM; Visser CA
J Nucl Med; 1999 Nov; 40(11):1866-73. PubMed ID: 10565782
[TBL] [Abstract][Full Text] [Related]
4. Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction. Implications for the pathophysiology of chronic myocardial hibernation.
Gerber BL; Vanoverschelde JL; Bol A; Michel C; Labar D; Wijns W; Melin JA
Circulation; 1996 Aug; 94(4):651-9. PubMed ID: 8772684
[TBL] [Abstract][Full Text] [Related]
5. Myocardial viability in ischemic heart disease: new directions and perspectives.
Previtali M
Ital Heart J; 2001 Feb; 2(2):93-9. PubMed ID: 11256549
[TBL] [Abstract][Full Text] [Related]
6. [Effect of myocardial viability and coronary revascularization on clinical outcome and prognosis: a follow-up study of 161 patients with coronary heart disease].
vom Dahl J; Altehoefer C; Büchin P; Sheehan FH; Schwarz ER; Koch KC; Schulz G; Uebis R; Schöndube F; Messmer BJ; Büll U; Hanrath P
Z Kardiol; 1996 Nov; 85(11):868-81. PubMed ID: 9064949
[TBL] [Abstract][Full Text] [Related]
7. [Thallium scintigraphy for determining myocardial vitality. Evaluation of the "stunned and hibernating myocardium"].
Nienaber CA; Carnarius H
Herz; 1994 Feb; 19(1):7-18. PubMed ID: 8150416
[TBL] [Abstract][Full Text] [Related]
8. [Hibernating myocardium and the 'no reflow' phenomenon: a study of absolute regional myocardial perfusion and glucose metabolism using positron emission tomography in chronic and acute heart disorders].
Maes A; Nuyts J
Verh K Acad Geneeskd Belg; 1997; 59(3):133-60. PubMed ID: 9490915
[TBL] [Abstract][Full Text] [Related]
9. Prediction of global left ventricular function after bypass surgery in patients with severe left ventricular dysfunction. Impact of pre-operative myocardial function, perfusion, and metabolism.
Pasquet A; Lauer MS; Williams MJ; Secknus MA; Lytle B; Marwick TH
Eur Heart J; 2000 Jan; 21(2):125-36. PubMed ID: 10637086
[TBL] [Abstract][Full Text] [Related]
10. Assessment of myocardial viability by positron emission tomography.
Segall G
Nucl Med Commun; 2002 Apr; 23(4):323-30. PubMed ID: 11930185
[TBL] [Abstract][Full Text] [Related]
11. [Scintigraphic evaluation of the ischemically damaged myocardium in patients with reduced left ventricular function. From clinical aspects to the cell].
Schwaiger M; Egert S; Brosius F
Z Kardiol; 1995; 84 Suppl 4():115-23. PubMed ID: 8585263
[TBL] [Abstract][Full Text] [Related]
12. Functional recovery after coronary revascularization for chronic coronary artery disease is dependent on maintenance of oxidative metabolism.
Gropler RJ; Geltman EM; Sampathkumaran K; Pérez JE; Moerlein SM; Sobel BE; Bergmann SR; Siegel BA
J Am Coll Cardiol; 1992 Sep; 20(3):569-77. PubMed ID: 1512335
[TBL] [Abstract][Full Text] [Related]
13. Prediction of improvement of contractile function in patients with ischemic ventricular dysfunction after revascularization by fluorine-18 fluorodeoxyglucose single-photon emission computed tomography.
Bax JJ; Cornel JH; Visser FC; Fioretti PM; van Lingen A; Huitink JM; Kamp O; Nijland F; Roelandt JR; Visser CA
J Am Coll Cardiol; 1997 Aug; 30(2):377-83. PubMed ID: 9247508
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of myocardial viability assessed by single photon emission computed tomography in patients with chronic ischaemic left ventricular dysfunction.
Schinkel AF; Bax JJ; Sozzi FB; Boersma E; Valkema R; Elhendy A; Roelandt JR; Poldermans D
Heart; 2002 Aug; 88(2):125-30. PubMed ID: 12117829
[TBL] [Abstract][Full Text] [Related]
15. Myocardial viability: contractile reserve or cell membrane integrity?
Dilsizian V
J Am Coll Cardiol; 1996 Aug; 28(2):443-6. PubMed ID: 8800123
[No Abstract] [Full Text] [Related]
16. Head-to-head comparison of exercise-redistribution-reinjection thallium single-photon emission computed tomography and low dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischemic dysfunction.
Vanoverschelde JL; D'Hondt AM; Marwick T; Gerber BL; De Kock M; Dion R; Wijns W; Melin JA
J Am Coll Cardiol; 1996 Aug; 28(2):432-42. PubMed ID: 8800122
[TBL] [Abstract][Full Text] [Related]
17. Identification of hibernating myocardium: a comparison between dobutamine echocardiography and study of perfusion and metabolism in patients with severe left ventricular dysfunction.
Mariani MA; Palagi C; Donatelli F; Mengozzi G; Biadi O; Vanoli G; Landoni C; Paolini G; Lucignani G; Fazio F
Am J Card Imaging; 1995 Jan; 9(1):1-8. PubMed ID: 7894227
[TBL] [Abstract][Full Text] [Related]
18. Clinical importance of viability assessment in chronic ischemic heart failure.
Calhoun WB; Mills RM; Drane WE
Clin Cardiol; 1996 May; 19(5):367-9. PubMed ID: 8723594
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of hibernating myocardium in patients with heart insufficiency].
La Canna G; Agricola E; Alfieri O
Ital Heart J Suppl; 2000 Oct; 1(10):1289-97. PubMed ID: 11068710
[TBL] [Abstract][Full Text] [Related]
20. Assessment of myocardial perfusion and metabolism for assessment of myocardial viability.
Beller GA
Q J Nucl Med; 1996 Mar; 40(1):55-67. PubMed ID: 8681014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
